日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Pasritamig, a First-in-Class, Bispecific T-Cell Engager Targeting Human Kallikrein 2, in Metastatic Castration-Resistant Prostate Cancer: A Phase I Study

帕利他米(Pasritamig)是一种首创的双特异性T细胞衔接剂,靶向人激肽释放酶2,用于治疗转移性去势抵抗性前列腺癌:一项I期研究

Stein, Mark N; Vinceneux, Armelle; Robbrecht, Debbie; Doger, Bernard; Autio, Karen A; Schweizer, Michael T; Calvo, Emiliano; Medina, Laura; Van Dongen, Marloes; Deville, Jean-Laurent; Bernard-Tessier, Alice; Ghosh, Debopriya; Shotts, Kristin; Shen, Fei; Jaiprasart, Pharavee; Chaudhary, Ruchi; Wu, Shujian; Cartee, Leanne; Schnepp, Robert; Gaut, Daria; Lauring, Josh; Wang, Sherry C; Villalobos, Victor M; Baldini, Capucine

Clinical and Translational Results from PORTER, a Multicohort Phase I Platform Trial of Combination Immunotherapy in Metastatic Castration-Resistant Prostate Cancer

PORTER研究的临床和转化结果:一项针对转移性去势抵抗性前列腺癌的联合免疫疗法多队列I期平台试验

Galsky, Matthew D; Autio, Karen A; Cabanski, Christopher R; Wentzel, Kristopher; Graff, Julie N; Friedlander, Terence W; Howes, Timothy R; Shotts, Kristin M; Densmore, Julie; Spasic, Marko; Da Silva, Diane M; Chen, Richard O; Lata, Jennifer; Skolnik, Jeffrey; Keler, Tibor; Yellin, Michael J; LaVallee, Theresa M; Fairchild, Justin; Boffo, Silvia; O'Donnell-Tormey, Jill; Dugan, Ute; Bhardwaj, Nina; Subudhi, Sumit K; Fong, Lawrence

Olaparib and Durvalumab in Patients with DNA Damage Repair Alterations and Biochemically Recurrent Prostate Cancer

奥拉帕尼和度伐利尤单抗治疗伴有DNA损伤修复改变和生化复发性前列腺癌的患者

Autio, Karen A; McHugh, Deaglan J; Rathkopf, Dana E; Xiao, Han; Merugu, Swathi; Wong, Phillip; Jan, Mehrin; Dorff, Tanya B; Heath, Elisabeth I; Scher, Howard I

A phase 1b/2 study of intermittent talazoparib plus temozolomide in patients with metastatic castration-resistant prostate cancer and no mutations in DNA damage response genes

一项针对转移性去势抵抗性前列腺癌且无DNA损伤反应基因突变患者的1b/2期研究,评估间歇性使用他拉唑帕尼联合替莫唑胺的疗效。

Autio, Karen A; Kyriakopoulos, Christos E; Palyca, Paul; Xiao, Han; Emamekhoo, Hamid; Danila, Daniel; Jan, Mehrin; Catharine, Victoria; Riedel, Elyn; Devitt, Michael; Laird, A Douglas; Scher, Howard I

Microsatellite Instability, Tumor Mutational Burden, and Response to Immune Checkpoint Blockade in Patients with Prostate Cancer

前列腺癌患者的微卫星不稳定性、肿瘤突变负荷和免疫检查点阻断疗法反应

Lenis, Andrew T; Ravichandran, Vignesh; Brown, Samantha; Alam, Syed M; Katims, Andrew; Truong, Hong; Reisz, Peter A; Vasselman, Samantha; Nweji, Barbara; Autio, Karen A; Morris, Michael J; Slovin, Susan F; Rathkopf, Dana; Danila, Daniel; Woo, Sungmin; Vargas, Hebert A; Laudone, Vincent P; Ehdaie, Behfar; Reuter, Victor; Arcila, Maria; Berger, Michael F; Viale, Agnes; Scher, Howard I; Schultz, Nikolaus; Gopalan, Anuradha; Donoghue, Mark T A; Ostrovnaya, Irina; Stopsack, Konrad H; Solit, David B; Abida, Wassim

Androgen Deprivation Therapy Drives a Distinct Immune Phenotype in Localized Prostate Cancer

雄激素剥夺疗法驱动局限性前列腺癌产生独特的免疫表型

Dallos, Matthew C; Obradovic, Aleksandar Z; McCann, Patrick; Chowdhury, Nivedita; Pratapa, Aditya; Aggen, David H; Gaffney, Christopher; Autio, Karen A; Virk, Renu K; De Marzo, Angelo M; Antonarakis, Emmanuel S; Scher, Howard I; Drake, Charles G; Rathkopf, Dana E

Marital Status, Living Arrangement, and Survival among Individuals with Advanced Prostate Cancer in the International Registry for Men with Advanced Prostate Cancer

国际晚期前列腺癌男性登记处中晚期前列腺癌患者的婚姻状况、居住安排和生存情况

Chen, Naiyu; McGrath, Colleen B; Ericsson, Caroline I; Vaselkiv, Jane B; Rencsok, Emily M; Stopsack, Konrad H; Guard, Hannah E; Autio, Karen A; Rathkopf, Dana E; Enting, Deborah; Bitting, Rhonda L; Mateo, Joaquin; Githiaka, Charles W; Chi, Kim N; Cheng, Heather H; Davis, Ian D; Anderson, Simon G; Badal, Simone Ann Marie; Bjartell, Anders; Russnes, Kjell M; Heath, Elisabeth I; Pomerantz, Mark M; Henegan, John C; Hyslop, Terry; Esteban, Emilio; Omlin, Aurelius; McDermott, Ray; Fay, Andre P; Popoola, Ademola Alabi; Ragin, Camille; Nowak, Joel; Gerke, Travis; Kantoff, Philip W; George, Daniel J; Penney, Kathryn L; Mucci, Lorelei A

Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States

美国黑人和白人晚期前列腺癌患者的疼痛及其与生存率的关系

Rencsok, Emily M; Slopen, Natalie; McManus, Hannah D; Autio, Karen A; Morgans, Alicia K; McSwain, Lawrence; Barata, Pedro; Cheng, Heather H; Dreicer, Robert; Gerke, Travis; Green, Rebecca; Heath, Elisabeth I; Howard, Lauren E; McKay, Rana R; Nowak, Joel; Pileggi, Shannon; Pomerantz, Mark M; Rathkopf, Dana E; Tagawa, Scott T; Whang, Young E; Ragin, Camille; Odedina, Folakemi T; Kantoff, Philip W; Vinson, Jake; Villanti, Paul; Haneuse, Sebastien; Mucci, Lorelei A; George, Daniel J

First-in-human phase I study of the OX40 agonist GSK3174998 with or without pembrolizumab in patients with selected advanced solid tumors (ENGAGE-1)

首次人体 I 期研究,评估 OX40 激动剂 GSK3174998 与或不与帕博利珠单抗联合治疗特定晚期实体瘤患者的疗效 (ENGAGE-1)

Postel-Vinay, Sophie; Lam, Vincent K; Ros, Willeke; Bauer, Todd M; Hansen, Aaron R; Cho, Daniel C; Stephen Hodi, F; Schellens, Jan H M; Litton, Jennifer K; Aspeslagh, Sandrine; Autio, Karen A; Opdam, Frans L; McKean, Meredith; Somaiah, Neeta; Champiat, Stephane; Altan, Mehmet; Spreafico, Anna; Rahma, Osama; Paul, Elaine M; Ahlers, Christoph M; Zhou, Helen; Struemper, Herbert; Gorman, Shelby A; Watmuff, Maura; Yablonski, Kaitlin M; Yanamandra, Niranjan; Chisamore, Michael J; Schmidt, Emmett V; Hoos, Axel; Marabelle, Aurelien; Weber, Jeffrey S; Heymach, John V

First-in-human, phase 1 study of PF-06753512, a vaccine-based immunotherapy regimen (VBIR), in non-metastatic hormone-sensitive biochemical recurrence and metastatic castration-resistant prostate cancer (mCRPC)

PF-06753512(一种基于疫苗的免疫疗法方案 (VBIR))在非转移性激素敏感性生化复发和转移性去势抵抗性前列腺癌 (mCRPC) 中的首次人体 1 期研究

Autio, Karen A; Higano, Celestia S; Nordquist, Luke; Appleman, Leonard J; Zhang, Tian; Zhu, Xin-Hua; Babiker, Hani; Vogelzang, Nicholas J; Prasad, Sandip M; Schweizer, Michael T; Madan, Ravi A; Billotte, Stephane; Cavazos, Nora; Bogg, Orlaith; Li, Ray; Chan, Kam; Cho, Helen; Kaneda, Megan; Wang, I-Ming; Zheng, Jenny; Tang, Szu-Yu; Hollingsworth, Robert; Kern, Kenneth A; Petrylak, Daniel P